TP53 and osteosarcoma: In addition to p53, genomic analysis of osteosarcomas has revealed copy number alterations of tumour suppressors RB1, WWOX, DLG2 and LSAMP to correspond to their enrichment at sites that exhibited complex breakage patterning characteristic of chromothripsis (table 1) [94].